REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT

视网膜脱离过程中 FGF 表达的调节

基本信息

项目摘要

The migration of retinal glial cells to extra-retinal sites is an important aspect of the pathophysiology of many proliferative retinopathies including proliferative vitreoretinopathy (PVR), and fibovascular-retinopathies such as diabetic vitreoretinopathy, retinopathy of prematurity, and traumatic vitreoretinopathy. The most attractive hypothesis which accounts for gliosis as a final common pathway in these pathologies is the secretion or release of a protein by the retina which stimulates the migration and growth of retinal glia under a variety of physiological and pathological stresses. We have purified a protein from normal bovine retina which elicites a migratory response in various neural glia, which we have named the retinal chemotactic protein. The research proposed here will provide an accurate determination of the physical properties of the retinal chemotactic protein and measure its effect on the migration, proliferation, and deposition of extracellular matrix by retinal glia in vitro. Studies of ocular cells in vitro will determine the physiological parameters regulating the release or secretion of this protein. This work will further establish the role of the retinal chemotactic protein in retinal detachment using the cat animal model. Finally, vitreous aspirates and celullar membranes removed during vitrectomy will be used to establish the role of this same protein in human pathologies involving glial migration and proliferation. This work will provide a basic understanding of the retina's response to injury. Since proliferated glial cells directly interfere with retinal reattachment, and may provide a structure upon which other ocular cell types may attach and divide, these results should lead to an enhanced ability to design new forms of treatment for these devastating retinal diseases.
视网膜胶质细胞向视网膜外位置的迁移是一个重要的过程

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leonard Martin Hjelmeland其他文献

Leonard Martin Hjelmeland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leonard Martin Hjelmeland', 18)}}的其他基金

Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8538398
  • 财政年份:
    2011
  • 资助金额:
    $ 22.22万
  • 项目类别:
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8328681
  • 财政年份:
    2011
  • 资助金额:
    $ 22.22万
  • 项目类别:
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8085950
  • 财政年份:
    2011
  • 资助金额:
    $ 22.22万
  • 项目类别:
EPIGENETIC AGING OF THE OXIDATIVE STRESS RESPONSE IN THE MOUSE RPE
小鼠 RPE 氧化应激反应的表观遗传老化
  • 批准号:
    7986159
  • 财政年份:
    2010
  • 资助金额:
    $ 22.22万
  • 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
  • 批准号:
    7138505
  • 财政年份:
    2006
  • 资助金额:
    $ 22.22万
  • 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
  • 批准号:
    7270099
  • 财政年份:
    2006
  • 资助金额:
    $ 22.22万
  • 项目类别:
REDOX CONTROL OF FGF GENE EXPRESSION IN AGING RPE
衰老 RPE 中 FGF 基因表达的氧化还原控制
  • 批准号:
    6384530
  • 财政年份:
    1986
  • 资助金额:
    $ 22.22万
  • 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
  • 批准号:
    3262655
  • 财政年份:
    1986
  • 资助金额:
    $ 22.22万
  • 项目类别:
REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT
视网膜脱离过程中 FGF 表达的调节
  • 批准号:
    2710920
  • 财政年份:
    1986
  • 资助金额:
    $ 22.22万
  • 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
  • 批准号:
    3262656
  • 财政年份:
    1986
  • 资助金额:
    $ 22.22万
  • 项目类别:

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
  • 批准号:
    EP/Y024540/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
  • 批准号:
    MR/Y008847/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
  • 批准号:
    BB/Y002180/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
  • 批准号:
    MR/Y003616/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
  • 批准号:
    MR/Y033698/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
  • 批准号:
    23H03716
  • 财政年份:
    2023
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
  • 批准号:
    23K06940
  • 财政年份:
    2023
  • 资助金额:
    $ 22.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了